# BioLife Plasma Services L.P. – FDA 483, Jun 25, 2026

Source: https://www.keypedia.com/records/483/biolife-plasma-services-lp/fd353072-18f5-4946-9a86-177692eeb616

> FDA 483 for BioLife Plasma Services L.P. on June 25, 2026. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: BioLife Plasma Services L.P.
- Inspection Date: 2026-06-25
- Product Type: biologics
- Office Name: Denver District Office
- Summary: An FDA inspection of BioLife Plasma Services L.P. in Thornton, CO, revealed two significant observations. The firm failed to adequately qualify equipment used in source plasma collection, including apheresis machines and donor screening monitors. Additionally, the donor screening station was found to be inadequately designed, preventing donors from maintaining proper seated posture during blood pressure measurements, which could impact the accuracy of donor eligibility determinations.

## Related Officers

- [Conor J. Mccarron](https://www.keypedia.com/people/conor-j-mccarron/280401e4-b080-4ba8-ab35-d3b16e91c2b1)

Company: https://www.keypedia.com/companies/biolife-plasma-services-lp/33e124d9-1ece-4b77-a05e-a471566b8d57

Office: https://www.keypedia.com/offices/denver-district-office/93b79063-390c-4759-af6c-5da7e388face